raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:457050

Autosomal dominant mitochondrial myopathy with exercise intolerance

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Childhood, Infancy
Status
active

A rare mitochondrial oxidative phosphorylation disorder due to nuclear DNA anomalies characterized by onset of slowly progressive proximal lower limb weakness and exercise intolerance in the first decade of life, followed by weakness of neck flexor, shoulder, and distal leg muscles. Facial muscles become involved still later in the disease course. Additional manifestations are restrictive pulmonary function and short stature. Laboratory studies reveal lactic acidemia and increased serum creatine kinase.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enAutosomal dominant mitochondrial myopathy with exercise intolerance
frMyopathie mitochondriale autosomique dominante avec intolérance à l'effort
deAutosomal-dominante mitochondriale Myopathie mit Belastungsintoleranz
esMiopatía mitocondrial autosómica dominante con intolerancia al ejercicio
itMiopatia mitocondriale autosomica dominante con intolleranza all'esercizio fisico
nlAutosomaal dominante mitochondriale myopathie met bewegingsintolerantie
ptMiopatia mitocondrial com intolerância ao exercício autossómica dominante
plAutosomalna dominująca miopatia mitochondrialna z nietolerancją wysiłku
csAutozomálně dominantní mitochondriální myopatie s intolerancí cvičení
ukАутосомно-домінантна мітохондріальна міопатія з непереносимістю фізичних навантажень
zh常染色体显性线粒体肌病伴运动性不耐受
trEgzersiz intoleransı ile seyreden otozomal dominant mitokondriyal miyopati

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM616209Evalidated
ICD-10G71.3NTBTattributedvalidated
ICD-115C53.2YNTBTattributedvalidated
MONDO0014532Evalidated
UMLSC4015513Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CHCHD10Disease-causing germline mutation(s) inAssessedHGNC:15559ENSG0000025047961590322q11.23coiled-coil-helix-coiled-coil-helix domain containing 1025193783[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families15 casesWorldwideCase(s)Validated9324076[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_9324076[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

13 annotations · validated 2018-12-03
HPOTerm (as annotated by Orphanet)Diagnostic
Frequent (79-30%)
HP:0009053Distal lower limb muscle weakness
HP:0003546Exercise intolerance
HP:0002151Increased circulating lactate concentration
HP:0012240Increased intramyocellular lipid droplets
HP:0040014Increased mitochondrial number
HP:0008180Mildly elevated creatine kinase
HP:0003722Neck flexor weakness
HP:0008994Proximal muscle weakness in lower limbs
HP:0003200Ragged-red muscle fibers
HP:0002091Restrictive ventilatory defect
HP:0004322Short stature
HP:0030319Weakness of facial musculature
Occasional (29-5%)
HP:0008997Proximal muscle weakness in upper limbs

Annotation source: 25193783[PMID]_9324076[PMID]

7

Sources for this card